skip to Main Content

Dr. Pant on Immunotherapy Combos and Upcoming Developments in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Shubham Pant, MD, associate medical director of the Clinical & Translational Research Center, associate professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses combination immunotherapies and upcoming developments in pancreatic cancer.

There is a lot of interest in immunotherapy in the field of oncology; however, this has been more of a challenge in pancreatic cancer, says Pant. However, combination immunotherapies, especially agents that target tumor microenvironments and create a less immune suppressive microenvironment, look promising. Read more . . . 

Back To Top